Reversible extralimbic paraneoplastic encephalopathies with large abnormalities on magnetic resonance images

Archives of Neurology

Volumn 66, Issue 2, 2009, Pages 268-271

  McKeon, Andrew ^a   Ahlskog, J Eric ^a   Britton, Jeffrey A ^a   Lennon, Vanda A ^b,c   Pittock, Sean J ^a,c  

^a Neurology Mayo Clinic SW   (United States)

^b Laboratory Medicine and Pathology   (United States)

^c MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; CYCLOPHOSPHAMIDE; DEXAMETHASONE; HU ANTIBODY; IMMUNOMODULATING AGENT; METHYLPREDNISOLONE;

ADULT; AGED; ARTICLE; BRAIN BIOPSY; BRAIN DISEASE; BREAST ADENOCARCINOMA; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CASE REPORT; DELIRIUM; DEMENTIA; EPILEPSY; FEMALE; HEMIANOPIA; HEMIPARESIS; HUMAN; HUMAN TISSUE; IMMUNOTHERAPY; LUNG CARCINOMA; MALE; NEUROLOGY; NUCLEAR MAGNETIC RESONANCE IMAGING; OUTPATIENT DEPARTMENT; PARANEOPLASTIC NEUROPATHY; PRIORITY JOURNAL; SENSORY NERVE CELL; SQUAMOUS CELL CARCINOMA; TREATMENT DURATION; UNITED STATES;

AGED; BIOLOGICAL MARKERS; BRAIN; BREAST NEOPLASMS; CARCINOMA; COGNITION DISORDERS; DISEASE PROGRESSION; FEMALE; HUMANS; IMMUNOTHERAPY; LUNG NEOPLASMS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; NEOPLASMS; PARANEOPLASTIC SYNDROMES, NERVOUS SYSTEM; PARESIS; SEIZURES; TREATMENT OUTCOME;

EID: 60549105579     PISSN: 00039942     EISSN: 15383687     Source Type: Journal    
DOI: 10.1001/archneurol.2008.556     Document Type: Article

References (11)

1. Gultekin SH, Rosenfeld MR, Voltz R, Eichen J, Posner JB, Dalmau J. Paraneoplastic limbic encephalitis: neurological symptoms, immunological findings and tumour association in 50 patients. Brain. 2000;123(pt 7):1481-1494.
2. Shams'ili S, Grefkens J, de Leeuw B, et al. Paraneoplastic cerebellar degeneration associated with antineuronal antibodies: analysis of 50 patients. Brain. 2003; 126(pt6):1409-1418.
3. Voltz R, Gultekin SH, Rosenfeld MR, et al. A serologic marker of paraneoplastic limbic and brain-stem encephalitis in patients with testicular cancer. N Engl J Med. 1999;340(23):1788-1795.
4. Vernino S, Lennon VA. Autoantibody profiles and neurological correlations of thymoma. Clin Cancer Res. 2004;10(21):7270-7275.
5. Dalmau J, Tüzün E, Wu HY, et al. Paraneoplastic anti-N-methyl-D-aspartate receptor encephalitis associated with ovarian teratoma. Ann Neurol. 2007;61(1):25-36.
6. Graus F, Keime-Guibert F, Reñe R, et al. Anti-Hu-associated paraneoplastic encephalomyelitis: analysis of 200 patients. Brain. 2001;124(pt6):1138-1148.
7. Pittock SJ, Lucchinetti CF, Lennon VA. Anti-neuronal nuclearautoantibody type 2: paraneoplastic accompaniments. Ann Neurol. 2003;53(5):580-587.
8. Ances BM, Vitaliani R, Taylor RA, et al. Treatment-responsive limbic encephalitis identified by neuropil antibodies: MRI and PET correlates. Brain. 2005;128 (pt 8):1764-1777.
9. Porta-Etessam J, Ruiz-Morales J, Millan JM, Ramos A, Martinez-Salio A, Berbel-García A. Epilepsia partialis continua and frontal features as a debut of anti-Hu paraneoplastic encephalomyelitis with focal frontal encephalitis. Eur J Neurol. 2001;8(4):359-360.
10. Pittock SJ, Kryzer TJ, Lennon VA. Paraneoplastic antibodies coexist and predict cancer, not neurological syndrome. Ann Neurol. 2004;56(5):715-719.
11. Pittock SJ, Lennon VA. Paraneoplastic autoimmunity affecting the nervous system. In: Baehring JM, Piepmeier JM, eds. Brain Tumors: Practical Guide to Diagnosis and Treatment. Vol 1. New York, NY: Informa Healthcare; 2007:515-536.